Year |
Citation |
Score |
2004 |
Wang Z, Chang L, Klein WL, Thatcher GR, Venton DL. Per-6-substituted-per-6-deoxy beta-cyclodextrins inhibit the formation of beta-amyloid peptide derived soluble oligomers. Journal of Medicinal Chemistry. 47: 3329-33. PMID 15189029 DOI: 10.1021/Jm034224E |
0.342 |
|
2003 |
Chang L, Bakhos L, Wang Z, Venton DL, Klein WL. Femtomole immunodetection of synthetic and endogenous amyloid-beta oligomers and its application to Alzheimer's disease drug candidate screening. Journal of Molecular Neuroscience : Mn. 20: 305-13. PMID 14501013 DOI: 10.1385/Jmn:20:3:305 |
0.324 |
|
2003 |
Park S, Hayes BL, Marankan F, Mulhearn DC, Wanna L, Mesecar AD, Santarsiero BD, Johnson ME, Venton DL. Regioselective covalent modification of hemoglobin in search of antisickling agents. Journal of Medicinal Chemistry. 46: 936-53. PMID 12620071 DOI: 10.1021/Jm020361K |
0.542 |
|
2002 |
Yu J, Bakhos L, Chang L, Holterman MJ, Klein WL, Venton DL. Per-6-substituted beta-cyclodextrin libraries inhibit formation of beta-amyloid-peptide (A beta)-derived, soluble oligomers. Journal of Molecular Neuroscience : Mn. 19: 51-5. PMID 12212793 DOI: 10.1007/S12031-002-0010-X |
0.528 |
|
2002 |
Yu J, Zhao Y, Holterman M, Venton DL. Cocaine detoxification by combinatorially substituted β-Cyclodextrin libraries Bioorganic and Medicinal Chemistry. 10: 3291-3299. PMID 12150875 DOI: 10.1016/S0968-0896(02)00205-5 |
0.516 |
|
2001 |
Lambert MP, Viola KL, Chromy BA, Chang L, Morgan TE, Yu J, Venton DL, Krafft GA, Finch CE, Klein WL. Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies. Journal of Neurochemistry. 79: 595-605. PMID 11701763 DOI: 10.1046/J.1471-4159.2001.00592.X |
0.497 |
|
2000 |
Park S, Wanna L, Johnson ME, Venton DL. A mass spectrometry screening method for antiaggregatory activity of proteins covalently modified by combinatorial library members: application to sickle hemoglobin. Journal of Combinatorial Chemistry. 2: 314-7. PMID 10891097 DOI: 10.1021/Cc9900798 |
0.543 |
|
1999 |
Yu J, Zhao Y, Holterman MJ, Venton DL. Combinatorial search of substituted beta-cyclodextrins for phosphatase-like activity. Bioorganic & Medicinal Chemistry Letters. 9: 2705-10. PMID 10509920 DOI: 10.1016/S0960-894X(99)00468-0 |
0.512 |
|
1999 |
Woodbury CP, Venton DL. Methods of screening combinatorial libraries using immobilized or restrained receptors Journal of Chromatography B: Biomedical Sciences and Applications. 725: 113-137. PMID 10226882 DOI: 10.1016/S0378-4347(99)00006-7 |
0.306 |
|
1997 |
Zhao YZ, van Breemen RB, Nikolic D, Huang CR, Woodbury CP, Schilling A, Venton DL. Screening solution-phase combinatorial libraries using pulsed ultrafiltration/electrospray mass spectrometry. Journal of Medicinal Chemistry. 40: 4006-12. PMID 9406591 DOI: 10.1021/Jm960729B |
0.341 |
|
1997 |
Van Breemen RB, Huang CR, Nikolic D, Woodbury CP, Zhao YZ, Venton DL. Pulsed ultrafiltration mass spectrometry: A new method for screening combinatorial libraries Analytical Chemistry. 69: 2159-2164. PMID 9183179 DOI: 10.1021/Ac970132J |
0.308 |
|
1995 |
Komiotis D, PananookoolnJ S, Zaw K, Dieter JP, Breton GL, Venton DL. Synthesis of dl-cis- and (4R,5R)-trans-7-[2,2-dimethyl-4-(phenylsulfonyl)-aminomethyl-1,3-dioxolan-5-yl]-5(Z)-heptenoic acid analogues as platelet thromboxane A2 receptor antagonist European Journal of Medicinal Chemistry. 30: 321-326. DOI: 10.1016/0223-5234(96)88240-7 |
0.366 |
|
1993 |
Borg C, Lam SCT, Dieter JP, Lim CT, Komiotis D, Venton DL, le Breton GC. Anti-peptide antibodies against the human blood platelet thromboxane A2/prostaglandin H2 receptor. Production, purification and characterization Biochemical Pharmacology. 45: 2071-2078. PMID 7685602 DOI: 10.1016/0006-2952(93)90018-R |
0.345 |
|
1992 |
Sun-Ok K, Chang T. L, Lam SCT, Hall SE, Komiotis D, Venton DL, Le Breton GC. Purification of the human blood platelet thromboxane A2/prostaglandin H2 receptor protein Biochemical Pharmacology. 43: 313-322. PMID 1739420 DOI: 10.1016/0006-2952(92)90294-S |
0.349 |
|
1992 |
Komiotis D, Lim CT, Dieter JP, Le Breton GC, Venton DL. PgH2 analogs as potential antiplatelet derivatives Journal of Medicinal Chemistry. 35: 3033-3039. PMID 1501231 DOI: 10.1021/Jm00094A017 |
0.347 |
|
1990 |
Le Breton GC, Lim CT, Vaidya CM, Venton DL. Thromboxane A2/prostaglandin H2 receptor antagonists Methods in Enzymology. 187: 406-414. PMID 2146463 DOI: 10.1016/0076-6879(90)87047-7 |
0.349 |
|
1990 |
Jonathan LT, Gbeassor M, Che CT, Fong HHS, Farnsworth NR, Le Breton GC, Venton DL. Pseudosemiglabrin, a platelet aggregation inhibitor from Tephrosia semiglabra Journal of Natural Products. 53: 1572-1574. PMID 2089123 DOI: 10.1021/Np50072A029 |
0.332 |
|
1989 |
Swann PG, Venton DL, Le Breton GC. Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets Febs Letters. 243: 244-246. PMID 2537230 DOI: 10.1016/0014-5793(89)80137-1 |
0.379 |
|
1987 |
Arora SK, Kattelman EJ, Lim CT, Le Breton GC, Venton DL. Preparation and biological evaluation of a potential photoaffinity label for the prostaglandin H2/thromboxane A2 receptor Journal of Medicinal Chemistry. 30: 918-924. PMID 2952799 DOI: 10.1021/Jm00388A029 |
0.355 |
|
1987 |
Kattelman EJ, Arora SK, Lim CT, Venton DL, Le Breton GC. A photoaffinity label for the thromboxane A2/prostaglandin H2 receptor in human blood platelets Febs Letters. 213: 179-183. PMID 2951273 DOI: 10.1016/0014-5793(87)81487-4 |
0.385 |
|
1986 |
Zulak IM, Puttemans ML, Schilling AB, Hall ER, Venton DL. A fast, nondestructive purification scheme for prostaglandin H2 using a nonaqueous, bonded-phase high-performance liquid chromatography system. Analytical Biochemistry. 154: 152-61. PMID 3085539 DOI: 10.1016/0003-2697(86)90509-9 |
0.326 |
|
1986 |
Kattelman EJ, Venton DL, Le Breton GC. Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548) Thrombosis Research. 41: 471-481. PMID 3008368 DOI: 10.1016/0049-3848(86)91692-0 |
0.334 |
|
1985 |
Brace LD, Venton DL, Le Breton GC. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets The American Journal of Physiology. 249. PMID 2409821 DOI: 10.1152/Ajpheart.1985.249.1.H8 |
0.301 |
|
1984 |
Le Breton GC, Hung SC, Ghali NI, Venton DL. 2-(6-carboxyhexyl)cyclopentanone hexylhydrazone: A potent inhibitor of the blood platelet cyclo-oxygenase Prostaglandins. 27: 543-551. PMID 6427851 DOI: 10.1016/0090-6980(84)90090-X |
0.387 |
|
1984 |
Ghali NI, Kattelman EJ, Hung SC, Schnorf KE, Le Breton GC, Venton DL. Synthesis of [17,18-3H]trans-13-azaprostanoic acid. A labeled probe for the PGH2/TXA2 receptor Prostaglandins. 27: 865-876. PMID 6091182 DOI: 10.1016/S0090-6980(84)80006-4 |
0.352 |
|
1983 |
Ghali NI, Venton DL, Hung SC, Le Breton GC. 2-(6-Carboxyhexyl)cyclopentanone hexylhydrazone. A potent and time-dependent inhibitor of platelet aggregation Journal of Medicinal Chemistry. 26: 1056-1060. PMID 6408259 DOI: 10.1002/Chin.198348154 |
0.359 |
|
1983 |
Mehta RR, Jenco JM, Chatterton RT, Venton D. Antagonism of the actions of estrogens, androgens and progesterone by anordrin (2 alpha, 17 alpha-diethynyl-A-nor-5 alpha-androstane-2 beta, 17 beta-diol dipropionate). Steroids. 40: 65-80. PMID 6297127 DOI: 10.1016/0039-128X(82)90113-1 |
0.308 |
|
1983 |
Hung SC, Ghali NI, Venton DL, Le Breton GC. Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes Bba - Biomembranes. 728: 171-178. PMID 6219702 DOI: 10.1016/0005-2736(83)90468-6 |
0.317 |
|
1982 |
Parise LV, Venton DL, Le Breton GC. Prostacyclin potentiates 13-azaprostanoic acid-induced platelet deaggregation Thrombosis Research. 28: 721-730. PMID 6301090 DOI: 10.1016/0049-3848(82)90097-4 |
0.369 |
|
1982 |
Hung SC, Ghali NI, Venton DL, Le Breton GC. Prostaglandin F2α antagonizes thromboxane A2-induced human platelet aggregation Prostaglandins. 24: 195-206. PMID 6293001 DOI: 10.1016/0090-6980(82)90145-9 |
0.345 |
|
1979 |
Le Breton GC, Venton DL, Enke SE, Halushka PV. 13-Azaprostanoic acid: A specific antagonist of the human blood platelet thromboxane/endoperoxide receptor Proceedings of the National Academy of Sciences of the United States of America. 76: 4097-4101. PMID 291066 DOI: 10.1073/Pnas.76.8.4097 |
0.377 |
|
1979 |
Venton DL, Enke SE, Le Breton GC. Azaprostanoic acid derivatives. Inhibitors of arachidonic acid induced Platelet aggregation Journal of Medicinal Chemistry. 22: 824-830. PMID 109614 DOI: 10.1002/Chin.197951337 |
0.371 |
|
Show low-probability matches. |